FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Alvogen Levothyroxine Sodium Tablets Recall

Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured…

Alvogen, Inc · Morristown, NJ

Risk level
Class II
Reported by FDA
Mar 8, 2023
Recall ID
D-0353-2023
Check your lot numberHow we source this data

Summary

Alvogen recalled Levothyroxine Sodium Tablets starting Feb 6, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0353-2023 on Mar 8, 2023. Reason: Sub-Potent Drug: Out of specification for assay at the 24 month interval. Status: Terminated.

Why it was recalled

Sub-Potent Drug: Out of specification for assay at the 24 month interval.

Product description

Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.

Lot numbers, UPCs & expiration codes

Lot # HE02221, Exp. 05/2023

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0353-2023
Classification
Class II
Status
Terminated
Recall initiated
Feb 6, 2023
FDA report date
Mar 8, 2023
Quantity
21,276 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Alvogen, Inc

Original FDA data

Every field from FDA enforcement report D-0353-2023, exactly as published.

Show all FDA fields
City
Morristown
State
NJ
Status
Terminated
Country
United States
Event ID
91654
Address
44 Whippany Rd Ste 107
Code information
Lot # HE02221, Exp. 05/2023
Postal code
07960-4558
Report date
Mar 8, 2023
Product type
Drugs
Recall number
D-0353-2023
Classification
Class II
Recalling firm
Alvogen, Inc
Product quantity
21,276 bottles
Termination date
Mar 18, 2024
Reason for recall
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Feb 6, 2023
Initial firm notification
Letter
Center classification date
Feb 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0353-2023, published Mar 8, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls